35 36. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997 Apr;51(4):1170-81. 37. Morena M, Cristol JP, Canaud B. Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif. 2000;18(3):191-9. 38. Álvarez AC, Leyva JR, López G. Relación entre la hiperhomocisteinemia y la insuficiencia renal Crónica. Ciencia Nicolaita 2005;40:77-90. 39. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial. 2002 Sep-Oct;15(5):329-37. 40. Channon KM, Guzik TJ. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol. 2002;53(4 Pt 1):515-24. 41. Galle J, Wanner C. Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation. Miner Electrolyte Metab. 1999;25(4-6):263-8.
Athenea Biomédica
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.